Search

Displaying results 1041 - 1050 of 10000 in total
  1. Drug

    Elotuzumab

    go.drugbank.com/drugs/DB06317
    ApprovedInvestigational

    Elotuzumab targets SLAMF7, also known as Signaling Lymphocytic Activation Molecule Family member 7, a cell surface glycoprotein. … Elotuzumab is a humanized IgG1 (Immunoglobulin G) monoclonal antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received

  2. Drug

    AZX-100

    go.drugbank.com/drugs/DB06323
    Investigational

  3. Drug

    XmAb 2513

    go.drugbank.com/drugs/DB06324
    Investigational

    XmAb 2513 is a humanized monoclonal antibody that targets the antigen CD30, a molecule expressed on the surface of a number of tumor cell types.

  4. Drug

    Latiglutenase

    go.drugbank.com/drugs/DB06326
    Investigational

  5. Drug

    Methoxyamine

    go.drugbank.com/drugs/DB06328
    Investigational

  6. Drug

    RG-7795

    go.drugbank.com/drugs/DB06329
    Investigational

  7. Drug

    4-O-Demethylpenclomedine

    go.drugbank.com/drugs/DB06331
    Experimental

    Categories: Heterocyclic Compounds, 1-RingSynonyms: 4-Dmpen, 4-Dm-pen
  8. Drug

    Tucidinostat

    go.drugbank.com/drugs/DB06334
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring
  9. Drug

    Elsiglutide

    go.drugbank.com/drugs/DB06336
    Investigational

  10. Drug

    ARG098

    go.drugbank.com/drugs/DB06338
    Experimental

    ARG098 (anti-Fas IgM monoclonal antibody) was studied in a Phase I clinical trial in 2007 involving patients with rheumatoid arthritis.